Cigna vs Molina Healthcare
CI and MOH side by side, both in accident and health insurance and medical. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CI and MOH compare
Cigna is the larger company, worth 7.4 times as much as Molina Healthcare ($78.8B against $10.7B).
Cigna grew revenue faster over the last twelve months (7.8% versus 2.6% for Molina Healthcare).
Cigna pays a dividend yielding 2.1%; Molina Healthcare does not pay one.
Cigna scores higher on the StockData Score (8 against 5 for Molina Healthcare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CI | MOH |
|---|---|---|
| Size and price | ||
| Market cap | $78.8B | $10.7B |
| Share price | $298.23 | $204.78 |
| Change, 1 year | −0.30% | 27.8% |
| Change, 5 years | 39.3% | −32.7% |
| Beta (5Y) | 0.33 | 0.25 |
| Employees | 68K | 19K |
| StockData Score | ||
| Total score | 8 (better) | 5 |
| Valuation score | 2 (better) | 1 |
| Growth score | 2 | 2 |
| Performance score | 0 | 0 |
| Health score | 2 | 2 |
| Dividend score | 2 (better) | 0 |
| Valuation | ||
| P/S | 0.3× | 0.2× (better) |
| P/B | 1.8× (better) | 2.6× |
| EV/EBITDA | 8.2× (better) | 14.9× |
| P/FCF | – | 39.4× |
| FCF yield | – | 2.5% |
| Growth | ||
| Revenue growth (TTM) | 7.8% (better) | 2.6% |
| Revenue growth, 5Y average | 11.4% | 18.5% (better) |
| Net income growth (TTM) | – | −101% |
| EPS growth (TTM) | – | −101% |
| EPS growth, 5Y average | −0.69% (better) | −4.5% |
| Profitability | ||
| Gross margin | 20.6% (better) | 12.6% |
| Operating margin | 3.5% (better) | 0.46% |
| Net margin | – | −0.02% |
| FCF margin | – | 0.61% |
| Return on equity | – | −0.16% |
| Return on invested capital | 12.1% | – |
| Financial health | ||
| Debt / equity | 0.75 (better) | 0.90 |
| Net debt / EBITDA | 1.94 (better) | −13.87 |
| Interest coverage | 7.2× (better) | 1.0× |
| Current ratio | 0.85 | 1.68 (better) |
| Altman Z-score | 2.80 | 4.08 (better) |
| Piotroski F-score | 7 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 2.1% | – |
| Years of dividend growth | 5 | – |
| Dividend growth, 5Y average | 173% | – |
| Buyback yield | 1.3% | 4.7% (better) |
| Shareholder yield | 3.4% | 4.7% (better) |
| Ownership | ||
| Held by institutions | 89.9% | 108% |
| Held by insiders | 0.41% | 1.5% |
| Insider net buying, 12 months | −$65.8M | −$3.5M (better) |
| Superinvestors holding | 4 (better) | 2 |
| Short interest, % of float | 2.6% | 5.6% |
Go deeper
- CI stock overview
- CI income statement
- CI valuation and score
- MOH stock overview
- MOH income statement
- MOH valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.